AMG 172 First in Human Study in Patients With Kidney Cancer

Sponsors and Collaborators

Amgen

 
Contact

Amgen Call Center


Continue Reading

886-572-6436
 
Investigators

MD

Amgen 

ClinicalTrials.gov Identifier

NCT01497821